{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:01:10Z","timestamp":1774472470387,"version":"3.50.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Microenvironment"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s12307-008-0010-7","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T09:33:41Z","timestamp":1210066421000},"page":"23-35","source":"Crossref","is-referenced-by-count":54,"title":["Bone Marrow Microenvironment and Tumor Progression"],"prefix":"10.1007","volume":"1","author":[{"given":"Christophe F.","family":"Chantrain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Feron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Marbaix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves A.","family":"DeClerck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,7]]},"reference":[{"key":"10_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335\u20132342","journal-title":"N Engl J Med"},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655\u20131664","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10_CR4","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","volume":"5","author":"TA Guise","year":"2005","unstructured":"Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ, Chirgwin JM (2005) Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer 5(Suppl):S46\u2013S53","journal-title":"Clin Breast Cancer"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.hoc.2007.08.007","volume":"21","author":"CS Mitsiades","year":"2007","unstructured":"Mitsiades CS, McMillin DW, Klippel S, Hideshima T, Chauhan D, Richardson PG, Munshi NC, Anderson KC (2007) The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies. Hematol Oncol Clin North Am 21:1007\u20131034","journal-title":"Hematol Oncol Clin North Am"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867","journal-title":"Nature"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrc925","volume":"2","author":"S Rafii","year":"2002","unstructured":"Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002) Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826\u2013835","journal-title":"Nat Rev Cancer"},{"key":"10_CR8","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1158\/0008-5472.CAN-06-2407","volume":"66","author":"RN Kaplan","year":"2006","unstructured":"Kaplan RN, Rafii S, Lyden D (2006) Preparing the \u201csoil\u201d: the premetastatic niche. Cancer Res 66:11089\u201311093","journal-title":"Cancer Res"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00662.2006","volume":"292","author":"GC Schatteman","year":"2007","unstructured":"Schatteman GC, Dunnwald M, Jiao C (2007) Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 292:H1\u201318","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/154732804323099163","volume":"13","author":"S Loges","year":"2004","unstructured":"Loges S, Fehse B, Brockmann MA, Lamszus K, Butzal M, Guckenbiehl M, Schuch G, Ergun S, Fischer U, Zander AR, Hossfeld DK, Fiedler W, Gehling UM (2004) Identification of the adult human hemangioblast. Stem Cells Dev 13:229\u2013242","journal-title":"Stem Cells Dev"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1242\/dev.125.4.725","volume":"125","author":"K Choi","year":"1998","unstructured":"Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G (1998) A common precursor for hematopoietic and endothelial cells. Development 125:725\u2013732","journal-title":"Development"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0925-4773(93)90096-G","volume":"42","author":"A Eichmann","year":"1993","unstructured":"Eichmann A, Marcelle C, Breant C, Le Douarin NM (1993) Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development. Mech Dev 42:33\u201348","journal-title":"Mech Dev"},{"key":"10_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2003-05-1684","volume":"103","author":"AS Bailey","year":"2004","unstructured":"Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder DA, Olson SB, Wong MH, Fleming WH (2004) Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 103:13\u201319","journal-title":"Blood"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1471-4914(03)00021-2","volume":"9","author":"SY Rabbany","year":"2003","unstructured":"Rabbany SY, Heissig B, Hattori K, Rafii S (2003) Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 9:109\u2013117","journal-title":"Trends Mol Med"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc1971","volume":"6","author":"F Bertolini","year":"2006","unstructured":"Bertolini F, Shaked Y, Mancuso P, Kerbel RS (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6:835\u2013845","journal-title":"Nat Rev Cancer"},{"key":"10_CR16","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1056\/NEJMc052670","volume":"353","author":"F Bertolini","year":"2005","unstructured":"Bertolini F, Mancuso P, Kerbel RS (2005) Circulating endothelial progenitor cells. N Engl J Med 353:2613\u20132616","journal-title":"N Engl J Med"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.RES.0000137877.89448.78","volume":"95","author":"C Urbich","year":"2004","unstructured":"Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343\u2013353","journal-title":"Circ Res"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1359\/jbmr.1999.14.5.700","volume":"14","author":"JE Dennis","year":"1999","unstructured":"Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI (1999) A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14:700\u2013709","journal-title":"J Bone Miner Res"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1242\/jcs.00369","volume":"116","author":"S Gronthos","year":"2003","unstructured":"Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827\u20131835","journal-title":"J Cell Sci"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/10428190500215076","volume":"46","author":"KC Kemp","year":"2005","unstructured":"Kemp KC, Hows J, Donaldson C (2005) Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 46:1531\u20131544","journal-title":"Leuk Lymphoma"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","volume":"8","author":"K Blanc Le","year":"2006","unstructured":"Le Blanc K (2006) Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8:559\u2013561","journal-title":"Cytotherapy"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","volume":"276","author":"DJ Prockop","year":"1997","unstructured":"Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71\u201374","journal-title":"Science"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1634\/stemcells.22-5-849","volume":"22","author":"SL Etheridge","year":"2004","unstructured":"Etheridge SL, Spencer GJ, Heath DJ, Genever PG (2004) Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849\u2013860","journal-title":"Stem Cells"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10245330500067249","volume":"10","author":"B Heissig","year":"2005","unstructured":"Heissig B, Ohki Y, Sato Y, Rafii S, Werb Z, Hattori K (2005) A role for niches in hematopoietic cell development. Hematology 10:247\u2013253","journal-title":"Hematology"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/scd.2006.15.4","volume":"15","author":"I Yaniv","year":"2006","unstructured":"Yaniv I, Stein J, Farkas DL, Askenasy N (2006) The tale of early hematopoietic cell seeding in the bone marrow niche. Stem Cells Dev 15:4\u201316","journal-title":"Stem Cells Dev"},{"key":"10_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2006.12.003","volume":"13","author":"RN Kaplan","year":"2007","unstructured":"Kaplan RN, Psaila B, Lyden D (2007) Niche-to-niche migration of bone-marrow-derived cells. Trends Mol Med 13:72\u201381","journal-title":"Trends Mol Med"},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/blood.V87.2.518.bloodjournal872518","volume":"87","author":"RS Taichman","year":"1996","unstructured":"Taichman RS, Reilly MJ, Emerson SG (1996) Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 87:518\u2013524","journal-title":"Blood"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","volume":"103","author":"D Visnjic","year":"2004","unstructured":"Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL (2004) Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103:3258\u20133264","journal-title":"Blood"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2004-06-2480","volume":"105","author":"RS Taichman","year":"2005","unstructured":"Taichman RS (2005) Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105:2631\u20132639","journal-title":"Blood"},{"key":"10_CR30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2004.07.004","volume":"118","author":"F Arai","year":"2004","unstructured":"Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T (2004) Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118:149\u2013161","journal-title":"Cell"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood-2004-11-4422","volume":"106","author":"SK Nilsson","year":"2005","unstructured":"Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106:1232\u20131239","journal-title":"Blood"},{"key":"10_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/1042819021000037985","volume":"44","author":"K Hattori","year":"2003","unstructured":"Hattori K, Heissig B, Rafii S (2003) The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk Lymphoma 44:575\u2013582","journal-title":"Leuk Lymphoma"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1196\/annals.1392.005","volume":"1106","author":"F Arai","year":"2007","unstructured":"Arai F, Suda T (2007) Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 1106:41\u201353","journal-title":"Ann N Y Acad Sci"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","volume":"109","author":"B Heissig","year":"2002","unstructured":"Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625\u2013637","journal-title":"Cell"},{"key":"10_CR35","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1038\/sj.onc.1210463","volume":"26","author":"V Takafuji","year":"2007","unstructured":"Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW (2007) An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 26:6361\u20136371","journal-title":"Oncogene"},{"key":"10_CR36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nm1417","volume":"12","author":"O Kollet","year":"2006","unstructured":"Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, Elson A, Lapidot T (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12:657\u2013664","journal-title":"Nat Med"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"43503","DOI":"10.1074\/jbc.M107736200","volume":"276","author":"GA McQuibban","year":"2001","unstructured":"McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503\u201343508","journal-title":"J Biol Chem"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/03008200390152133","volume":"1","author":"X Yu","year":"2003","unstructured":"Yu X, Collin-Osdoby P, Osdoby P (2003) SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity. Connect Tissue Res 44 Suppl 1:79\u201384","journal-title":"Connect Tissue Res 44 Suppl"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni813","volume":"3","author":"I Petit","year":"2002","unstructured":"Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687\u2013694","journal-title":"Nat Immunol"},{"key":"10_CR40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1152\/physiol.00025.2005","volume":"20","author":"HG Kopp","year":"2005","unstructured":"Kopp HG, Avecilla ST, Hooper AT, Rafii S (2005) The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 20:349\u2013356","journal-title":"Physiology (Bethesda)"},{"key":"10_CR41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539\u2013545","journal-title":"Lancet"},{"key":"10_CR42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm740","volume":"8","author":"K Hattori","year":"2002","unstructured":"Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D, Rafii S (2002) Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 8:841\u2013849","journal-title":"Nat Med"},{"key":"10_CR43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.193.9.1005","volume":"193","author":"K Hattori","year":"2001","unstructured":"Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005\u20131014","journal-title":"J Exp Med"},{"key":"10_CR44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature00821","volume":"417","author":"HP Gerber","year":"2002","unstructured":"Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N (2002) VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954\u2013958","journal-title":"Nature"},{"key":"10_CR45","doi-asserted-by":"crossref","unstructured":"Allavena P, Sica A, Solinas G, Porta C, Mantovani A (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66:1\u20139","DOI":"10.1016\/j.critrevonc.2007.07.004"},{"key":"10_CR46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000092969","volume":"13","author":"KE Visser de","year":"2006","unstructured":"de Visser KE, Coussens LM (2006) The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118\u2013137","journal-title":"Contrib Microbiol"},{"key":"10_CR47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","volume":"7","author":"KE Visser de","year":"2005","unstructured":"de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411\u2013423","journal-title":"Cancer Cell"},{"key":"10_CR48","first-page":"854","volume":"63","author":"H Maeda","year":"1998","unstructured":"Maeda H, Akaike T (1998) Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 63:854\u2013865","journal-title":"Biochemistry (Mosc)"},{"key":"10_CR49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71\u201378","journal-title":"Nat Rev Cancer"},{"key":"10_CR50","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.190.10.1375","volume":"190","author":"JD Hudson","year":"1999","unstructured":"Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190:1375\u20131382","journal-title":"J Exp Med"},{"key":"10_CR51","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1158\/0008-5472.CAN-06-1823","volume":"67","author":"JB Wyckoff","year":"2007","unstructured":"Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67:2649\u20132656","journal-title":"Cancer Res"},{"key":"10_CR52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263\u2013266","journal-title":"Cell"},{"key":"10_CR53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)00139-2","volume":"103","author":"LM Coussens","year":"2000","unstructured":"Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481\u2013490","journal-title":"Cell"},{"key":"10_CR54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/labinvest.3700232","volume":"85","author":"J Wedemeyer","year":"2005","unstructured":"Wedemeyer J, Galli SJ (2005) Decreased susceptibility of mast cell-deficient Kit(W)\/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab Invest 85:388\u2013396","journal-title":"Lab Invest"},{"key":"10_CR55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ijc.2910420110","volume":"42","author":"JR Starkey","year":"1988","unstructured":"Starkey JR, Crowle PK, Taubenberger S (1988) Mast-cell-deficient W\/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48\u201352","journal-title":"Int J Cancer"},{"key":"10_CR56","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1073\/pnas.0601807103","volume":"103","author":"H Nozawa","year":"2006","unstructured":"Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A 103:12493\u201312498","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR57","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","volume":"13","author":"LM Coussens","year":"1999","unstructured":"Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382\u20131397","journal-title":"Genes Dev"},{"key":"10_CR58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557\u2013563","journal-title":"Nature"},{"key":"10_CR59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.moh.0000219664.26528.da","volume":"13","author":"HG Kopp","year":"2006","unstructured":"Kopp HG, Ramos CA, Rafii S (2006) Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 13:175\u2013181","journal-title":"Curr Opin Hematol"},{"key":"10_CR60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","volume":"431","author":"F Balkwill","year":"2004","unstructured":"Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 431:405\u2013406","journal-title":"Nature"},{"key":"10_CR61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0002-9440(10)65365-5","volume":"154","author":"R Salcedo","year":"1999","unstructured":"Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154:1125\u20131135","journal-title":"Am J Pathol"},{"key":"10_CR62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm1400","volume":"12","author":"DK Jin","year":"2006","unstructured":"Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D, Rafii S (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12:557\u2013567","journal-title":"Nat Med"},{"key":"10_CR63","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737\u2013744","journal-title":"Nat Cell Biol"},{"key":"10_CR64","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","volume":"94","author":"S Huang","year":"2002","unstructured":"Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134\u20131142","journal-title":"J Natl Cancer Inst"},{"key":"10_CR65","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/0008-5472.CAN-03-0160","volume":"64","author":"CF Chantrain","year":"2004","unstructured":"Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA (2004) Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64:1675\u20131686","journal-title":"Cancer Res"},{"key":"10_CR66","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-04-3770","volume":"65","author":"S Jodele","year":"2005","unstructured":"Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM, DeClerck YA (2005) The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 65:3200\u20133208","journal-title":"Cancer Res"},{"key":"10_CR67","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.CIR.0000096483.29777.50","volume":"108","author":"C Urbich","year":"2003","unstructured":"Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108:2511\u20132516","journal-title":"Circulation"},{"key":"10_CR68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","volume":"6","author":"L Yang","year":"2004","unstructured":"Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian LM, Carbone DP, Lin PC (2004) Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:409\u2013421","journal-title":"Cancer Cell"},{"key":"10_CR69","first-page":"159","volume":"1766","author":"M Palma De","year":"2006","unstructured":"De Palma M, Naldini L (2006) Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta 1766:159\u2013166","journal-title":"Biochim Biophys Acta"},{"key":"10_CR70","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1096\/fj.05-5137fje","volume":"20","author":"B Li","year":"2006","unstructured":"Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20:1495\u20131497","journal-title":"FASEB J"},{"key":"10_CR71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1593\/neo.05592","volume":"8","author":"PK Goon","year":"2006","unstructured":"Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD (2006) Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 8:79\u201388","journal-title":"Neoplasia"},{"key":"10_CR72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1189\/jlb.0506309","volume":"80","author":"C Lamagna","year":"2006","unstructured":"Lamagna C, Bergers G (2006) The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 80:677\u2013681","journal-title":"J Leukoc Biol"},{"key":"10_CR73","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ncb1288","volume":"7","author":"S Song","year":"2005","unstructured":"Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G (2005) PDGFRbeta + perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870\u2013879","journal-title":"Nat Cell Biol"},{"key":"10_CR74","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood-2004-01-0336","volume":"104","author":"I Rajantie","year":"2004","unstructured":"Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104:2084\u20132086","journal-title":"Blood"},{"key":"10_CR75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M Palma De","year":"2005","unstructured":"De Palma M, Venneri MA, Galli R, Sergi SL, Politi LS, Sampaolesi M, Naldini L (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211\u2013226","journal-title":"Cancer Cell"},{"key":"10_CR76","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/sj.bjc.6602476","volume":"92","author":"G Coukos","year":"2005","unstructured":"Coukos G, Benencia F, Buckanovich RJ, Conejo-Garcia JR (2005) The role of dendritic cell precursors in tumour vasculogenesis. Br J Cancer 92:1182\u20131187","journal-title":"Br J Cancer"},{"key":"10_CR77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/bcr1541","volume":"8","author":"V Muller","year":"2006","unstructured":"Muller V, Hayes DF, Pantel K (2006) Recent translational research: circulating tumor cells in breast cancer patients. Breast Cancer Res 8:110","journal-title":"Breast Cancer Res"},{"key":"10_CR78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.pdm.0000213463.98763.b9","volume":"15","author":"YI Elshimali","year":"2006","unstructured":"Elshimali YI, Grody WW (2006) The clinical significance of circulating tumor cells in the peripheral blood. Diagn Mol Pathol 15:187\u2013194","journal-title":"Diagn Mol Pathol"},{"key":"10_CR79","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jcb.10522","volume":"89","author":"YX Sun","year":"2003","unstructured":"Sun YX, Wang JC, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS (2003) Expression of CXCR4, CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89:462\u2013473","journal-title":"J Cell Biochem"},{"key":"10_CR80","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.4049\/jimmunol.167.8.4747","volume":"167","author":"H Geminder","year":"2001","unstructured":"Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP, Ben Baruch A (2001) A possible role for CXCR4, its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167:4747\u20134757","journal-title":"J Immunol"},{"key":"10_CR81","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA (2005) Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 10:169\u2013180","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10_CR82","doi-asserted-by":"crossref","unstructured":"Strahm B, Durbin AD, Sexsmith E, Malkin D (2008) The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma. Clin Exp Metastasis 25:1\u201310","DOI":"10.1007\/s10585-007-9094-6"},{"key":"10_CR83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1593\/neo.06670","volume":"9","author":"L Zhang","year":"2007","unstructured":"Zhang L, Yeger H, Das B, Irwin MS, Baruchel S (2007) Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 9:36\u201346","journal-title":"Neoplasia"},{"key":"10_CR84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50\u201356","journal-title":"Nature"},{"key":"10_CR85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2004.10.003","volume":"29","author":"L Goldberg-Bittman","year":"2005","unstructured":"Goldberg-Bittman L, Sagi-Assif O, Meshel T, Nevo I, Levy-Nissenbaum O, Yron I, Witz IP, Ben Baruch A (2005) Cellular characteristics of neuroblastoma cells: regulation by the ELR-CXC chemokine CXCL10 and expression of a CXCR3-like receptor. Cytokine 29:105\u2013117","journal-title":"Cytokine"},{"key":"10_CR86","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","volume":"116","author":"T Yin","year":"2006","unstructured":"Yin T, Li L (2006) The stem cell niches in bone. J Clin Invest 116:1195\u20131201","journal-title":"J Clin Invest"},{"key":"10_CR87","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy GR (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544\u20131549","journal-title":"J Clin Invest"},{"key":"10_CR88","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.1199","volume":"198","author":"S Kitazawa","year":"2002","unstructured":"Kitazawa S, Kitazawa R (2002) RANK ligand is a prerequisite for cancer-associated osteolytic lesions. J Pathol 198:228\u2013236","journal-title":"J Pathol"},{"key":"10_CR89","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504\u20131508","journal-title":"Science"},{"key":"10_CR90","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1381612013397807","volume":"7","author":"PJ Kostenuik","year":"2001","unstructured":"Kostenuik PJ, Shalhoub V (2001) Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des 7:613\u2013635","journal-title":"Curr Pharm Des"},{"key":"10_CR91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.01.059","volume":"228","author":"Y Sohara","year":"2005","unstructured":"Sohara Y, Shimada H, DeClerck YA (2005) Mechanisms of bone invasion and metastasis in human neuroblastoma. Cancer Lett 228:203\u2013209","journal-title":"Cancer Lett"},{"key":"10_CR92","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0037-1963(01)90020-4","volume":"38","author":"NS Callander","year":"2001","unstructured":"Callander NS, Roodman GD (2001) Myeloma bone disease. Semin Hematol 38:276\u2013285","journal-title":"Semin Hematol"},{"key":"10_CR93","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1158\/0008-5472.CAN-04-2853","volume":"65","author":"Y Sohara","year":"2005","unstructured":"Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, DeClerck YA (2005) Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Res 65:1129\u20131135","journal-title":"Cancer Res"},{"key":"10_CR94","unstructured":"Ara T, Shimada H, Keshelava N, Metelitsa LS, Song LP, Groshen SG, Seeger RC, DeClerck YA (2008) IL-6 promotes the growth and survival of neuroblastoma cells. Cancer Res (in press)"},{"key":"10_CR95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/asheducation-2000.1.147","volume":"72","author":"KC Anderson","year":"2000","unstructured":"Anderson KC, Kyle RA, Dalton WS, Landowski T, Shain K, Jove R, Hazlehurst L, Berenson J (2000) Multiple myeloma: new insights and therapeutic approaches. Hematology (Am Soc Hematol Educ Program) 72:147\u2013165","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10_CR96","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1359\/jbmr.070802","volume":"22","author":"JB Kim","year":"2007","unstructured":"Kim JB, Leucht P, Lam K, Luppen C, Ten Berge D, Nusse R, Helms JA (2007) Bone regeneration is regulated by wnt signaling. J Bone Miner Res 22:1913\u20131923","journal-title":"J Bone Miner Res"},{"key":"10_CR97","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","volume":"25","author":"C Niehrs","year":"2006","unstructured":"Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469\u20137481","journal-title":"Oncogene"},{"key":"10_CR98","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","volume":"97","author":"N Voorzanger-Rousselot","year":"2007","unstructured":"Voorzanger-Rousselot N, Goehrig D, Journe F, Doriath V, Body JJ, Clezardin P, Garnero P (2007) Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 97:964\u2013970","journal-title":"Br J Cancer"},{"key":"10_CR99","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2007-03-082529","volume":"110","author":"J Qian","year":"2007","unstructured":"Qian J, Xie J, Hong S, Yang J, Zhang L, Han X, Wang M, Zhan F, Shaughnessy JD Jr., Epstein J, Kwak LW, Yi Q (2007) Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood 110:1587\u20131594","journal-title":"Blood"},{"key":"10_CR100","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1158\/0008-5472.CAN-06-4666","volume":"67","author":"N Giuliani","year":"2007","unstructured":"Giuliani N, Morandi F, Tagliaferri S, Lazzaretti M, Donofrio G, Bonomini S, Sala R, Mangoni M, Rizzoli V (2007) Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment. Cancer Res 67:7665\u20137674","journal-title":"Cancer Res"},{"key":"10_CR101","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1359\/JBMR.050802","volume":"20","author":"BT Feeley","year":"2005","unstructured":"Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR (2005) Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res 20:2189\u20132199","journal-title":"J Bone Miner Res"},{"key":"10_CR102","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820\u2013827","journal-title":"Nature"},{"key":"10_CR103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/BD-2007-26106","volume":"26","author":"B Psaila","year":"2006","unstructured":"Psaila B, Kaplan RN, Port ER, Lyden D (2006) Priming the \u2018soil\u2019 for breast cancer metastasis: the pre-metastatic niche. Breast Dis 26:65\u201374","journal-title":"Breast Dis"},{"key":"10_CR104","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.20050959","volume":"202","author":"B Heissig","year":"2005","unstructured":"Heissig B, Rafii S, Akiyama H, Ohki Y, Sato Y, Rafael T, Zhu Z, Hicklin DJ, Okumura K, Ogawa H, Werb Z, Hattori K (2005) Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med 202:739\u2013750","journal-title":"J Exp Med"},{"key":"10_CR105","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1127592","volume":"313","author":"Y Shaked","year":"2006","unstructured":"Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, Kerbel RS (2006) Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313:1785\u20131787","journal-title":"Science"},{"key":"10_CR106","first-page":"4342","volume":"63","author":"F Bertolini","year":"2003","unstructured":"Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS (2003) Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 63:4342\u20134346","journal-title":"Cancer Res"},{"key":"10_CR107","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.bjc.6602952","volume":"94","author":"G Furstenberger","year":"2006","unstructured":"Furstenberger G, von Moos R, Lucas R, Thurlimann B, Senn HJ, Hamacher J, Boneberg EM (2006) Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 94:524\u2013531","journal-title":"Br J Cancer"},{"key":"10_CR108","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1158\/0008-5472.CAN-07-0905","volume":"67","author":"Y Shaked","year":"2007","unstructured":"Shaked Y, Kerbel RS (2007) Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Res 67:7055\u20137058","journal-title":"Cancer Res"},{"key":"10_CR109","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3324\/haematol.11455","volume":"92","author":"V Rosti","year":"2007","unstructured":"Rosti V, Massa M, Campanelli R, De Amici M, Piccolo G, Perfetti V (2007) Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome. Haematologica 92:1291\u20131292","journal-title":"Haematologica"},{"key":"10_CR110","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387\u20132392","journal-title":"Science"},{"key":"10_CR111","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","volume":"527","author":"S Hatse","year":"2002","unstructured":"Hatse S, Princen K, Bridger G, De Clercq E, Schols D (2002) Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527:255\u2013262","journal-title":"FEBS Lett"}],"container-title":["Cancer Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12307-008-0010-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T21:51:16Z","timestamp":1631224276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12307-008-0010-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,7]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s12307-008-0010-7","relation":{},"ISSN":["1875-2292","1875-2284"],"issn-type":[{"value":"1875-2292","type":"print"},{"value":"1875-2284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,7]]}}}